More about Hereditary Diffuse Gastric Cancer
Many CDH1 carriers develop gastric cancer if the stomach is not removed. Lifetime risk estimates range from 42% for men and 33% for women by age 80 in a 2019 study of families found through broader genetic testing (Roberts, JAMA Oncology) to 70% for men and 56% for women in MedlinePlus Genetics, and the 2020 international guidelines recognize that risk varies between families (Blair, Lancet Oncology). Gastric cancer in HDGC families tends to be early-onset (median age 40-50 years, much younger than sporadic gastric cancer median of 65+ years) and typically presents with advanced stage disease due to insidious diffuse infiltration.
Keep reading about Hereditary Diffuse Gastric Cancer
HDGC gastric cancer has worse prognosis than sporadic diffuse gastric cancer with lower resection rates due to extensive peritoneal involvement. Some CDH1 mutations (particularly truncating mutations) also increase lobular breast cancer risk in female carriers (40% by age 70-80), distinct from intestinal breast cancer subtypes. The insidious nature of diffuse gastric cancer makes early detection challenging with conventional endoscopy, as early disease appears as subtle thickening without discrete masses.
What are the symptoms of Hereditary Diffuse Gastric Cancer?
These are common symptoms of Hereditary Diffuse Gastric Cancer, and how strong they are varies from person to person.
- Diffuse-type gastric adenocarcinoma
- No early warning signs in early disease
- Dyspepsia and upper abdominal discomfort in advanced cases
- Weight loss and anemia
- Associated lobular breast cancer in some families
- Metastatic disease in advanced cases
Who gets Hereditary Diffuse Gastric Cancer?
Estimates of stomach cancer risk for CDH1 carriers vary. MedlinePlus Genetics gives a lifetime chance of 70% for men and 56% for women. A 2019 study of 41 families found through clinical and multigene panel genetic testing at a commercial laboratory estimated 42% for men and 33% for women by age 80, and its authors say earlier estimates were likely too high because they came from families with several stomach cancers (Roberts, JAMA Oncology). Women carriers also face a higher risk of lobular breast cancer. Early-onset gastric cancer common, occurring in 20s-40s in some carriers; some patients develop cancer by age 30. Autosomal dominant inheritance with approximately 50% of offspring of affected parents inheriting mutation.
Specific CDH1 mutation type (truncating vs. missense, location) influences penetrance and organ involvement. Ethnic and geographic variations in founder mutations documented (specific mutations common in certain populations). Inactivating mutations required (single allele sufficient due to haploinsufficiency). Approximately 5-10% of early-onset gastric cancer cases carry CDH1 mutations.
Next steps: find trials you might fitsee what is being testedget help payingget alerts
Side effects people have reported to the FDA
Side effects people have reported to the FDA
Real-world side effect reports from the FDA Adverse Event Reporting System (FAERS). Includes both FDA-approved drugs and investigational therapies from active clinical trials. Click any drug to see what patients reported.
Loading side effect data...
Diagnosis and genetic testing
Genetic testing for Hereditary Diffuse Gastric Cancer
Genetic testing can confirm a diagnosis, guide treatment decisions, and identify family members who may be at risk.
Finding labs...
Trusted Hereditary Diffuse Gastric Cancer resources
Reputable organizations and medical references for learning more about Hereditary Diffuse Gastric Cancer, including disease registries, foundation resources, and clinical guidelines.
- MedlinePlus Genetics - Hereditary diffuse gastric cancer
- Roberts et al., JAMA Oncol 2019 - Comparison of CDH1 Penetrance Estimates in Clinically Ascertained Families vs Families Ascertained for Multiple Gastric Cancers
- Blair et al., Lancet Oncol 2020 - Hereditary diffuse gastric cancer: updated clinical practice guidelines
- NIH GARD - Hereditary Diffuse Gastric Cancer
- NORD - Stomach Cancer (includes hereditary diffuse gastric cancer)
- American Gastroenterological Association